Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dekorsy

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
European Journal of Nuclear Medicine and Molecular Imaging|November 4, 2022
TSPO PET signal using [<sup>18</sup>F]GE180 is associated with survival in recurrent gliomasStefanie Quach, Adrien Holzgreve, Lena Kaiser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2023
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapyConrad-Amadeus Voltin, Andrea Paccagnella, Michael Winkelmann, et al.
Frontiers in Oncology|February 16, 2023
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [<sup>18</sup>F]SiTATERalf S Eschbach, Markus Hofmann, Lukas Späth, et al.
Acta Neuropathologica Communications|September 11, 2023
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophagesLorraine Weidner, Julia Lorenz, Stefanie Quach, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
European Journal of Nuclear Medicine and Molecular Imaging|November 4, 2022
TSPO PET signal using [<sup>18</sup>F]GE180 is associated with survival in recurrent gliomasStefanie Quach, Adrien Holzgreve, Lena Kaiser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2023
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapyConrad-Amadeus Voltin, Andrea Paccagnella, Michael Winkelmann, et al.
Frontiers in Oncology|February 16, 2023
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [<sup>18</sup>F]SiTATERalf S Eschbach, Markus Hofmann, Lukas Späth, et al.
Acta Neuropathologica Communications|September 11, 2023
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophagesLorraine Weidner, Julia Lorenz, Stefanie Quach, et al.
Pageof 8